Walleye Capital’s Clearmind Medicine CMND Stock Holding History

Walleye Capital’s Portfolio CMND Stock Details CMND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-32	Closed	-$61.7K	–	4997
2023 Q3	$61.7K	Buy	+32	New	+$147K	﹤0.01%	4124
2023 Q1	–	Sell	-4	Closed	-$140K	–	3979
2022 Q4	$140K	Buy	+4	New	+$191K	﹤0.01%	2242

Other funds holding CMND

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Walleye Capital's CMND Position: Q4 2023 in Review

Walleye Capital sold out of Clearmind Medicine (CMND) in Q4 2023, closing a stake of 32 shares — an estimated $61.7K sold.

Walleye Capital first reported a position in CMND in Q4 2022 and held it in 2 quarters. The position peaked at $140K in Q4 2022. 1 fund tracked by Wall St. Rank holds CMND as of Q4 2023.

Walleye Capital reported no remaining Clearmind Medicine position as of Q4 2023 after selling out during the quarter.
Walleye Capital sold 32 Clearmind Medicine shares in Q4 2023, an estimated $61.7K.
Walleye Capital first reported a position in Clearmind Medicine in Q4 2022 and held it in 2 quarters.
Walleye Capital's Clearmind Medicine position peaked at $140K in Q4 2022.
1 fund tracked by Wall St. Rank held Clearmind Medicine as of Q4 2023.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.